A study at the University of Pennsylvania demonstrated that a single dose of psilocybin rapidly and durably alleviates both chronic pain and anxiodepressive behaviors in mouse models. Targeting specific brain circuits, psilocybin’s action on serotonin receptors highlights its potential as a novel non-opioid therapeutic for comorbid pain and mood disorders, addressing a critical unmet medical need.